GYRE NASDAQ · Healthcare · FY 2025-12-31
GYRE THERAPEUTICS, INC.
ABV
EPV
EBV
DBV
fair value / share
buy at or below (margin of safety applied)
margin-of-safety band
current price
values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Earnings Suspect
Confidence
●●○
Medium · 2/4
Price
5.750 USD
Market cap
525.1M USD
P / B
4.95
P / E
287.50
EPS
0.020
DPS / yield
— (0.0%)
NAV / share
1.491
Graham number
0.723
Z'' score
7.11
Piotroski F
3 / 9
Beneish M
-2.15
ROIC vs WACC
11.3%
vs 35.5%
See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.
Subscribe to unlock this and every other tab for every company.
See the full ABV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EPV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full EBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.
See the full DBV lens breakdown — gates, steps, and verdict.
Subscribe to unlock this and every other tab for every company.